Transcription of MEDICAL POLICY – 2.01
{{id}} {{{paragraph}}}
Example: dental hygienist
MEDICAL POLICY – 2.01
MEDICAL POLICY Orthopedic Applications of Platelet-Rich Plasma BCBSA Ref. POLICY : Effective Date: July 1, 2021 RELATED MEDICAL POLICIES: Last Revised: June 1, 2021 Recombinant and Autologous Platelet-Derived Growth Factors for Replaces: N/A Wound Healing and Other Non Orthopedic Conditions Prolotherapy Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used with Autologous Bone Marrow). Select a hyperlink below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION. EVIDENCE REVIEW | REFERENCES | HISTORY. Clicking this icon returns you to the hyperlinks menu above.
outcomes, health status measures, quality of life, morbid events, resource utilization, and treatment-related morbidity. The single open-labeled RCT failed to show any statistically significant reduction in the need for surgical revision with the addition of PRP treatment. The
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: